tirzepatide for perimenopause leads to significant weight loss in women Blog - Your Wellness Center

As a GLP-1 receptor agonist sharing 94% structural homology with human GLP-1, the medication binds to and activates receptors located primarily in the gastrointestinal tract, pancreas, and brain, triggering a cascade of physiological responses that extend far beyond simple blood sugar control

The second hormone in tirzepatide, glucose-dependent insulinotropic polypeptide (GIP), also impacts insulin production and slows digestion, thereby reducing hunger and improving blood sugar

What makes GLP-1 particularly effective is that it only stimulates insulin when blood glucose levels are elevated, reducing the risk of hypoglycemia (low blood sugar)

Anti-genotoxic effects of tea catechins against reactive oxygen species in human lymphoblastoid cells